| Responders (n = 60) | Non-responders (n = 60) | P value between resp. and non-resp. | |||||
---|---|---|---|---|---|---|---|---|
Pre-n-3 PUFAs | Post-n-3 PUFAs | P value | Pre-n-3 PUFAs | Post-n-3 PUFAs | P value | Pre-n-3 PUFAs | Delta (post- and pre-n-3 PUFAs) | |
Gender | 26 men (43Â %) and 34 women (57Â %) | 30 men (50Â %) and 30 women (50Â %) | NS | Â | ||||
Age (years) | 32.02 ± 1.11 years | 31.1 ± 1.16 years | NS |  | ||||
BMI (kg/m²) | 29.3 ± 0.5 | 29.3 ± 0.5 | NS | 27.8 ± 0.5 | 28.0 ± 0.5 | 0.0007 | NS | NS |
Triacylglycerolsa (mmol/L) | 1.61 ± 0.09 | 0.99 ± 0.06 | <0.0001 | 1.03 ± 0.06 | 1.20 ± 0.07 | <0.0001 | <0.0001 | <0.0001 |
Cholesterol (mmol/L) | Â | Â | Â | Â | Â | Â | Â | Â |
 Total | 4.94 ± 0.12 | 4.83 ± 0.13 | NS | 4.77 ± 0.13 | 4.87 ± 0.14 | NS | NS | 0.0264 |
 LDL | 2.87 ± 0.11 | 2.94 ± 0.12 | NS | 2.79 ± 0.12 | 2.84 ± 0.13 | NS | NS | NS |
 HDLa | 1.33 ± 0.05 | 1.44 ± 0.05 | <0.0001 | 1.50 ± 0.05 | 1.48 ± 0.05 | NS | 0.0142 | 0.0001 |
Ratio TC/HDL-C | 3.90 ± 0.13 | 3.59 ± 0.14 | <0.0001 | 3.33 ± 0.12 | 3.48 ± 0.14 | 0.0054 | 0.0018 | <0.0001 |
Apo-B 100 (g/L) | 0.89 ± 0.03 | 0.91 ± 0.03 | NS | 0.83 ± 0.03 | 0.88 ± 0.03 | 0.0015 | NS | NS |
Ratio LDL/Apo-B | 3.28 ± 0.06 | 3.20 ± 0.05 | NS | 3.36 ± 0.06 | 3.20 ± 0.07 | 0.0098 | NS | NS |
Glucose (mmol/L)a | 5.15 ± 0.06 | 5.17 ± 0.06 | NS | 4.94 ± 0.05 | 5.04 ± 0.07 | NS | 0.0155 | NS |
Insulin (pmol/L)a,* | 84.93 ± 3.47 | 80.91 ± 3.35 | NS | 75.31 ± 3.31 | 82.70 ± 3.90 | 0.0456 | 0.0226 | NS |
CRPa(mg/L) | 2.78 ± 0.47 | 2.69 ± 0.40 | NS | 2.87 ± 0.68 | 3.06 ± 0.83 | NS | NS | NS |